©The Author(s) 2016.
World J Gastroenterol. Sep 14, 2016; 22(34): 7692-7707
Published online Sep 14, 2016. doi: 10.3748/wjg.v22.i34.7692
Published online Sep 14, 2016. doi: 10.3748/wjg.v22.i34.7692
Table 1 General overview molecules/molecular pathways involved in the peritoneal metastatic cascade
| Steps peritoneal metastatic cascade | Molecules/molecular pathways |
| Detachment from the primary tumor | Spontaneous tumor cell shedding: |
| E-cadherin ↓ | |
| N-cadherin ↑ | |
| EMT | |
| PC1 and PC2 ↑ | |
| Interstitial fluid pressure ↑ | |
| Peroperative seeding tumor cells during surgery | |
| Peritoneal transport | Muscinous ascites |
| Actin microfilament system | |
| Lammelipodia, filipodia | |
| Attachment to distant peritoneum | Transmesothelial dissemination: |
| ICAM-1 ↑, PECAM-1, VCAM-1 ↑ | |
| TNF-α, IL-1β, IL-6, IFN-γ | |
| β1 integrin subunit | |
| CD43, CD44 | |
| Hyaluronan | |
| Translymphatic dissemination: | |
| Lymphatic stomata | |
| Milky spots | |
| Invasion into the subperitoneal space | Rounding of mesothelial cells: |
| HGF/SF ↑ | |
| c-Met ↑ | |
| Destruction of the mesothelial monolayer: | |
| Tumor-induced apoptosis | |
| Fas ligand/Fas | |
| Adherence to the basement membrane: | |
| Integrines | |
| Invasion of the peritoneal-blood barrier: | |
| MMP-1, MMP-2, MMP-7, MMP-9, MMP-13, MMP-14 ↑ | |
| TIMP-1, TIMP-2, TIMP-3, TIMP-4 | |
| uPA/uPAR | |
| plasminogen activator inhibitor -1 and -2 | |
| Proliferation and angiogenesis | Proliferation: |
| EGFR, EGF, TGFα | |
| IGF-1, IGF-Binding Protein-3 | |
| Angiogenesis: | |
| HIF-1α, HIF-1β | |
| VEGF/VEGFR |
Table 2 Intra-operative peritoneal lavage: detection method, timing and outcome data
| Ref. | Patients, n | Method of detection | Peritoneal lavage fluid | Timing of sampling | Intraperitoneal free cancer cells |
| Kirstensen et al[73] | 237 | PCR | 200-600 mL 0.9% NaCl | After | 8.01% |
| Nishikawa et al[74] | 410 | Cytology | 200 mL 0.9% NaCl | Before | 7.60% |
| Lloyd et al[75] | 125 | Immunobead RT-PCR | 100 mL 0.9% NaCl | Before | 12.80% |
| After | 29.60% | ||||
| Bae et al[76] | 145 | Cytology | 100 mL 0.9% NaCl | Before | 4.10% |
| Noura et al[77] | 697 | Cytology | 100 mL 0.9% NaCl | Before | 2.20% |
| Altomare et al[79] | 29 | Thin-Prep | 150 mL 0.9% NaCl | Before | 13.80% |
| After | 2.60% | ||||
| RT-PCR | 150 mL 0.9% NaCl | Before | 37.90% | ||
| After | 41.40% | ||||
| Rossi Del Monte et al[78] | 48 | Cytology | 250 mL 0.9% NaCl | Before | 0.00% |
| Immunofluorescence | 250 mL 0.9% NaCl | Before | 17.00% | ||
| qRT-PCR | 250 mL 0.9% NaCl | Before | 42.00% |
Table 3 Overview matrix metalloproteinases[124]
| MMP | Name | Producing Cells | Substrates |
| MMP-1 | Collagenase | Fibroblasts, synovial cells, chondrocyte | Collagen I, II, III, X |
| MMP-2 | Gelatinase | Fibroblasts, chrondrocyte, mesangium | Gelatin, collagen IV, V, VII, XI |
| endothelial cells, cancer cells | Laminin, fibronectin, elastin | ||
| MMP-3 | Stromelysin-1 | Synovial cells, chondrocyte, fibroblasts | Proteoglycan, collagen III, IV, VII, IX, elastin |
| MMP-7 | Matrilysin | Cancer cells, macrophage | Proteoglycan, gelatin, fibronectin |
| elastin, collagen IV, laminin | |||
| MMP-8 | Neutrophil, Collagenase | Neutrophil | Collagen I, II, III |
| MMP-9 | Gelatinase B | Neutrophil, macrophage, thromboblast | Gelatin, collagen III, IV, V |
| osteoclast, cancer cells, T-lymphocyte | α2 chain, Elastin | ||
| MMP-10 | Stromelysin-2 | Cancer cells, T-lymphocyte | Collagen III, IV, V, fibronectin, gelatin |
| MMP-11 | Stromelysin-3 | Cancer cells, macrophage, mesangium | Fibronectin, laminin, proteoglycan, gelatin |
| MMP-12 | Metalloestelase | Macrophage | Elastin |
| MMP-13 | Collagenase-3 | Chondrocyte, cancer cells | Collagen I, II, III |
| MMP-14 | MT1-MMP | Cancer cells, fibroblasts | Collagen I, II, III, gelatin, Laminin |
| Fibronectin, vitronectin, proteoglycan | |||
| MMP-15 | MT2-MMP | Cancer cells, fibroblasts | Fibronectin, aggrecan, tenascin |
| MMP-16 | MT3-MMP | Neuronal cell | Collagen III, gelatin, fibronectin |
| MMP-17 | MT4-MMP | Unknown | Unknown |
| MMP-20 | Enamelysin | Odontoblast | Amelogenin, gelatin |
| MMP-24 | MT5-MMP | Unknown | Unknown |
| MMP-25 | MT6-MMP | Unknown | Unknown |
| TIMP-1 | Tissue, extracellular fluid | Complex formation with pro-MMP-9 and MMPs | |
| TIMP-2 | Tissue, extracellular fluid | Complex formation with pro-MMP-9, inhibition of MMP-2 degradation |
- Citation: Lemoine L, Sugarbaker P, Van der Speeten K. Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneum. World J Gastroenterol 2016; 22(34): 7692-7707
- URL: https://www.wjgnet.com/1007-9327/full/v22/i34/7692.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i34.7692